The interventional impairment of olfactory sensory perception using a specific intranasal device resulted in a reduction in body weight, improved insulin sensitivity, and decreased preferences for sweet foods in subjects aged ≤ 50 years with obesity on a low-calorie diet compared to a control group. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.